The global legionella testing market size is expected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing incidence of legionella-related disorders and rising awareness about their preventive management.
Legionella is a type of bacteria that cause legionnaire’s disease, a severe form of pneumonia or a respiratory infection such as flu-like illness. Legionella testing refers to a range of monitoring procedures to detect the presence of the bacteria and aids in determining the cause of pneumonia in a patient. Once a patient is affected by the bacteria, it is very likely that the patient had to undergo intensive care and hospitalization as the illness turns out to be severe without proper medication and treatment.
For long, the illness has been regarded as a major public health issue globally due to rising cases. Over 4,568 cases of legionnaire disease were registered in 2013, according to the Centers for Disease Control and Prevention (CDC). The disease is primarily caused due to water pollution and lack of proper water storage of industries as well as residential areas. Since legionella bacteria can thrive in hot water, various industries depending on water storage are vulnerable to legionella contamination. Schools, restaurants, hospitals, and massive plumbing systems among others are some of the key arena for possible spread of these harmful waterborne bacteria. As a result, the demand for accurate and timely diagnosis of legionella and related infections is high in urban areas too.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing incidence of legionella-related disorders and rising awareness about the preventive management are expected to drive the market growth.
- Introduction of advanced technology such as immunodiagnostic technology and automation for the diagnostic devices is a key driver of the market.
- Governments’ initiatives encouraging the development of innovative testing devices and funding for extensive research are key factors that drive the market.
- Lack of skilled technicians for handling the testing and lack of advanced testing facilities in developing regions are key challenges that can hamper the market growth.
Scope of the Report
The report on the global legionella testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Legionella Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Applications (Water Testing [Microbial Culture, DFA Stain, PCR, and Others] and IVD Testing [Blood Culture, Urine Antigen Test, DFA Stain, PCR, and Others])
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Alere, Inc.; Roche Diagnostics; Thermo Fischer Scientific, Inc.; and Becton, Dickinson and Company (BD).
|
Market Segment Insights
Microbial culture segment is projected to constitute a large key market share
Based on applications, the legionella testing market is bifurcated into water testing and IVD testing. The water testing is further divided as microbial culture, DFA stain, PCR, and others while the IVD testing segment consists of blood culture, urine antigen test, DFA stain, PCR, and others. The microbial culture segment is expected to hold a key share of the market during the forecast period due to wide implementation of government laws that has made the testing mandatory. In 2020, the microbial culture accounted for a large market share mainly due to extensive water research, followed by PCR. PCR offers advantages such as prompt and precise diagnosis as well as repeatable outcomes. As a result, it is widely used as a bacterial testing tool.
On the other hand, the IVD testing segment is projected to exhibit a healthy CAGR during the projected period and the urine antigen analyses represented a key market share within the segment. The most significant disadvantage to traditional research methods is the time limit, which can take up to weeks to produce results and fail to deliver reliable results on time. Presumptive care or a pause in treatment may occur in the absence of accurate diagnostics and delays in diagnosis can obstruct a proper treatment care. Traditional research methods are time-consuming and require manual intervention, which can lead to contamination and have an effect on the results. Since it eliminates the burden of manual efforts, automation can save up to 50% of time in diagnostic procedures. Furthermore, the outcomes are dependable, accurate, and sensitive. The findings of diagnostic lab automation are standardized and repeatable. As a result, advanced rapid diagnostic methods are becoming more common and demand for the diagnostics is expected to grow in the coming years.
Asia Pacific is anticipated to dominate the market
On the basis of regions, the global legionella testing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period owing to growing geriatric population and wide prevalence of the infections. Moreover, the rising disposable income of a large number of the population and increasing penetration of legionella testing products through a global distribution network in the region are expected to drive the market development in Asia Pacific.
In 2019, Europe held a large market share owing to wide investment for legionella research. Rapid introduction of various legislation by some governments such as the United Kingdom and Germany, have made the testing mandatory, which is proved to be key driver for the segment. This is largely due to widespread public knowledge of legionella and associated diseases among a large number of the population in the region. As a result of the legionella outbreak in the summer of 2020, European countries have mandated quarterly legionella testing for cooling towers.
Segments
Segments Covered in the Report
The global legionella testing market has been segmented on the basis of
Applications
- Water Testing
- Microbial Culture
- DFA Stain
- PCR
- Others
- IVD Testing
- Blood Culture
- Urine Antigen Test
- DFA Stain
- PCR
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Alere, Inc.
- Roche Diagnostics
- Thermo Fischer Scientific, Inc.
- Becton, Dickinson and Company (BD)
Competitive Landscape
Key players competing in the legionella testing market are Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Alere, Inc.; Roche Diagnostics; Thermo Fischer Scientific, Inc.; and Becton, Dickinson and Company (BD). Mergers and acquisitions, partnerships, product releases, and geographic extensions are some of the business tactics used by these firms to enhance their market posititon.
Request For Customization
Enquiry Before Buying
Speak With Analyst
